Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308508295> ?p ?o ?g. }
- W4308508295 endingPage "1258" @default.
- W4308508295 startingPage "1243" @default.
- W4308508295 abstract "Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and lacks specific targeted therapeutic agents. The current mechanistic evidence from cell-based studies suggests that the matricellular protein SPARC has a tumor-promoting role in TNBC; however, data on the clinical relevance of SPARC expression/secretion by tumor and stromal cells in TNBC are limited. Here, we analyzed by immunohistochemistry the prognostic value of tumor and stromal cell SPARC expression in 148 patients with non-metastatic TNBC and long follow-up (median: 5.4 years). We also quantified PD-L1 and PD-1 expression. We detected SPARC expression in tumor cells (42.4%), cancer-associated fibroblasts (CAFs; 88.1%), tumor-associated macrophages (77.1%), endothelial cells (75.2%) and tumor-infiltrating lymphocytes (9.8%). Recurrence-free survival was significantly lower in patients with SPARC-expressing CAFs. Multivariate analysis showed that SPARC expression in CAFs was an independent prognostic factor. We also detected tumor and stromal cell SPARC expression in TNBC cytosols, and in patient-derived xenografts and cell lines. Furthermore, we analyzed publicly available single-cell mRNA sequencing data and found that in TNBC, SPARC is expressed by different CAF subpopulations, including myofibroblasts and inflammatory fibroblasts that are involved in tumor-related processes. We then showed that fibroblast-secreted SPARC had a tumor-promoting role by inhibiting TNBC cell adhesion and stimulating their motility and invasiveness. Overall, our study demonstrates that SPARC expression in CAFs is an independent prognostic marker of poor outcome in TNBC. Patients with SPARC-expressing CAFs could be eligible for anti-SPARC targeted therapy." @default.
- W4308508295 created "2022-11-12" @default.
- W4308508295 creator A5014622051 @default.
- W4308508295 creator A5020037049 @default.
- W4308508295 creator A5026447642 @default.
- W4308508295 creator A5031089086 @default.
- W4308508295 creator A5033810683 @default.
- W4308508295 creator A5035249331 @default.
- W4308508295 creator A5036595403 @default.
- W4308508295 creator A5037398109 @default.
- W4308508295 creator A5038458593 @default.
- W4308508295 creator A5053668514 @default.
- W4308508295 creator A5062426069 @default.
- W4308508295 creator A5072494043 @default.
- W4308508295 creator A5073780219 @default.
- W4308508295 date "2022-11-30" @default.
- W4308508295 modified "2023-10-18" @default.
- W4308508295 title "<scp>SPARC</scp> in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activity" @default.
- W4308508295 cites W1562222070 @default.
- W4308508295 cites W1594566844 @default.
- W4308508295 cites W171910026 @default.
- W4308508295 cites W1787080797 @default.
- W4308508295 cites W1966498047 @default.
- W4308508295 cites W1969706233 @default.
- W4308508295 cites W1975227850 @default.
- W4308508295 cites W1975300167 @default.
- W4308508295 cites W1975935257 @default.
- W4308508295 cites W1978414874 @default.
- W4308508295 cites W1979281206 @default.
- W4308508295 cites W1987239717 @default.
- W4308508295 cites W2001362512 @default.
- W4308508295 cites W2003122962 @default.
- W4308508295 cites W2005214712 @default.
- W4308508295 cites W2006692397 @default.
- W4308508295 cites W2011482983 @default.
- W4308508295 cites W2016983859 @default.
- W4308508295 cites W2033699710 @default.
- W4308508295 cites W2039572697 @default.
- W4308508295 cites W2045152605 @default.
- W4308508295 cites W2050004148 @default.
- W4308508295 cites W2055624262 @default.
- W4308508295 cites W2065610761 @default.
- W4308508295 cites W2073716382 @default.
- W4308508295 cites W2085934079 @default.
- W4308508295 cites W2086834665 @default.
- W4308508295 cites W2095724936 @default.
- W4308508295 cites W2101160783 @default.
- W4308508295 cites W2106521718 @default.
- W4308508295 cites W2107028932 @default.
- W4308508295 cites W2112434826 @default.
- W4308508295 cites W2114364048 @default.
- W4308508295 cites W2123297535 @default.
- W4308508295 cites W2132883779 @default.
- W4308508295 cites W2134878729 @default.
- W4308508295 cites W2136178883 @default.
- W4308508295 cites W2136799968 @default.
- W4308508295 cites W2158204812 @default.
- W4308508295 cites W2171072331 @default.
- W4308508295 cites W2171137965 @default.
- W4308508295 cites W2347175105 @default.
- W4308508295 cites W2402636472 @default.
- W4308508295 cites W2471915619 @default.
- W4308508295 cites W2527140315 @default.
- W4308508295 cites W2530225599 @default.
- W4308508295 cites W2560367415 @default.
- W4308508295 cites W2564952819 @default.
- W4308508295 cites W2578402280 @default.
- W4308508295 cites W2583135417 @default.
- W4308508295 cites W2611492002 @default.
- W4308508295 cites W2755696550 @default.
- W4308508295 cites W2771978163 @default.
- W4308508295 cites W2786031287 @default.
- W4308508295 cites W2887614555 @default.
- W4308508295 cites W2889213939 @default.
- W4308508295 cites W2949177718 @default.
- W4308508295 cites W2958208890 @default.
- W4308508295 cites W2969621080 @default.
- W4308508295 cites W2971607016 @default.
- W4308508295 cites W3002684299 @default.
- W4308508295 cites W3011445145 @default.
- W4308508295 cites W3026844837 @default.
- W4308508295 cites W3048888372 @default.
- W4308508295 cites W3116164295 @default.
- W4308508295 cites W3141665744 @default.
- W4308508295 cites W3157584900 @default.
- W4308508295 cites W3163187433 @default.
- W4308508295 cites W4308508295 @default.
- W4308508295 doi "https://doi.org/10.1002/ijc.34345" @default.
- W4308508295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36346290" @default.
- W4308508295 hasPublicationYear "2022" @default.
- W4308508295 type Work @default.
- W4308508295 citedByCount "6" @default.
- W4308508295 countsByYear W43085082952022 @default.
- W4308508295 countsByYear W43085082952023 @default.
- W4308508295 crossrefType "journal-article" @default.
- W4308508295 hasAuthorship W4308508295A5014622051 @default.
- W4308508295 hasAuthorship W4308508295A5020037049 @default.
- W4308508295 hasAuthorship W4308508295A5026447642 @default.